How many ulcerative colitis patients are currently taking opioid medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Opioid Use in Ulcerative Colitis Patients

Approximately 22-27% of ulcerative colitis patients become chronic opioid users, with an additional 9-12% demonstrating opioid misuse patterns.

Epidemiological Data on Opioid Use

The prevalence of opioid use in UC patients varies by clinical setting and definition:

Chronic Opioid Use Rates

  • 22.3% of UC patients in a Danish nationwide cohort of 30,416 patients became chronic opioid users over a median follow-up of 8.80 years 1
  • 27.4% of Crohn's disease patients (for comparison) became chronic users in the same population-based study, suggesting UC rates are slightly lower but still substantial 1
  • In a single-center U.S. study of 497 UC patients, 9% without functional gastrointestinal disorders (FGID) were chronic opioid users 2

Acute Hospital Setting

  • 41% of UC patients hospitalized with acute severe ulcerative colitis (ASUC) received opioids during their hospital stay 3
  • 11% of hospitalized ASUC patients received high-dose opioids (≥40 oral morphine equivalents per day) 3
  • Among hospitalized IBD patients, 89% consumed narcotics during their admission 4

Opioid Misuse Patterns

  • 1.3% of UC patients without FGID demonstrated prescription opioid misuse (defined as filling prescriptions from ≥4 prescribers and ≥4 pharmacies in 12 months) 2
  • 12.8% of UC patients with concurrent FGID demonstrated opioid misuse patterns, representing a 5-fold increased risk 2

High-Risk Subpopulations

Patients with Functional Overlay

  • 36% of UC patients with concurrent FGID were chronic opioid users, compared to 9% without FGID, representing a 4.5-fold increased risk 2
  • FGID diagnosis was the strongest predictor of both chronic use and misuse in UC patients 2

Post-Surgical Patients

  • Surgery was the strongest predictor of chronic opioid use in UC, with an adjusted hazard ratio of 4.81 (95% CI 4.20-5.52) 1
  • 47% of hospitalized IBD patients were discharged with opioid prescriptions, with 71% of these being opioid-naïve prior to admission 4
  • 70% of ASUC patients with high opioid use during hospitalization received opioid prescriptions at discharge, compared to only 10% with low/no use 3

Other Risk Factors

  • Age ≥50 years was associated with a 2.62-fold increased risk of chronic opioid use in UC patients 1
  • Hypnotics/sedatives use conferred a 2.11-fold increased risk of chronic opioid use 1
  • Tobacco use increased the risk of chronic opioid use (OR 2.53,95% CI 1.06-6.08) 2
  • Anxiety disorders were associated with a 3.17-fold increased risk of chronic opioid use 2

Clinical Implications

Guideline Recommendations Against Opioid Use

  • Opioids should not be prescribed for chronic gastrointestinal pain in UC or other disorders of gut-brain interaction 5
  • The British Society of Gastroenterology recommends against long-term opioid use in inflammatory bowel disease due to associations with serious infections, increased mortality, and poor outcomes 6
  • Withdrawal of opioid drugs is specifically recommended in acute severe UC to avoid precipitating colonic dilatation 5

Ineffectiveness of Opioids for IBD Pain

  • Pain scores did not improve during hospitalization despite opioid use, with less than a 1-point change in daily average pain from admission to discharge 4
  • The daily average pain score among opioid users was 4.65 ± 2.16, with patients consuming an average of 20 ± 25 mg morphine equivalents per day without meaningful pain relief 4
  • Opioid-naïve patients used similar doses to those on opioids prior to admission, yet experienced no better pain control 4

Adverse Outcomes Associated with Opioid Use

  • High opioid use (≥40 OME/day) was associated with a median 3-day delay in biologic rescue therapy initiation in ASUC patients 3
  • Approximately 6% of chronic opioid users develop narcotic bowel syndrome, characterized by paradoxical worsening of abdominal pain despite continued or escalating doses 5, 6
  • Opioid use in UC is associated with increased risk of serious infections and mortality 6

Common Pitfalls

Avoid prescribing opioids as a bridge therapy without a concrete plan for discontinuation, as this frequently leads to chronic use and discharge prescriptions in previously opioid-naïve patients 4

Do not overlook functional gastrointestinal disorders in UC patients, as this concurrent diagnosis dramatically increases both opioid use (4.5-fold) and misuse (5-fold) risk 2

Recognize that tramadol carries the same risks as traditional opioids, including addiction potential and adverse events, despite being perceived as "safer" 5, 6

References

Research

Opioid use and misuse in ulcerative colitis.

World journal of gastrointestinal pharmacology and therapeutics, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Use in Crohn's Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a 23‑year‑old woman with a four‑month history of diarrhea with mucus, anemia, abdominal pain that improves after defecation, a normal erythrocyte sedimentation rate, and a family history of colorectal carcinoma in a relative diagnosed at age 60, what is the most likely diagnosis?
In a patient with suspected ulcerative colitis (UC) presenting with bloody diarrhea, which part of the bowel is most likely to be affected?
What is the likely diagnosis for a 25-year-old patient with abdominal pain, bloody diarrhea, and weight loss, a positive guaiac (fecal occult blood test) stool test, and a family history of similar complaints?
What's the next step for a 52-year-old male patient with Ulcerative Colitis (UC) whose symptoms have resolved after 4 weeks of treatment?
What is the most likely diagnosis in a 23‑year‑old woman with a four‑month history of watery diarrhea containing mucus, anemia, abdominal pain that improves after defecation, a normal erythrocyte sedimentation rate, and a father diagnosed with colon cancer at age 60?
What DEA schedule are tricyclic antidepressants classified under?
I have burning suprapubic pain and a sensation of incomplete voiding despite a negative urine dipstick for infection; what are the possible causes and recommended evaluation?
Can I take prednisone to treat my peripheral edema and mild shortness of breath, which I believe are caused by my antihypertensive medications (amlodipine, enalapril, clonidine)?
What vitamin D supplementation regimen is recommended for a patient with a serum 25‑hydroxyvitamin D level of 23.44 ng/mL?
How should I adjust the insulin regimen for an adult with diabetes mellitus who is on basal NPH (Neutral Protamine Hagedorn) insulin 30 U at 8 AM and uses a carbohydrate‑to‑insulin ratio of 1 U per 8 g carbohydrate, now receiving high‑dose prednisone 60 mg daily, with capillary glucose readings of 263 mg/dL at 5 PM, 251 mg/dL at 8 PM, 351 mg/dL at 10 PM, and 421 mg/dL at 1 AM?
What is the recommended treatment for peripheral arterial disease (PAD) presenting with intermittent claudication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.